Nostos Genomics is an AI-driven company dedicated to improving rare disease diagnostics through its variant interpretation platform called AION. The company helps genetic testing labs provide fast and accurate diagnoses for patients with genetic diseases, thus addressing the bottleneck in genomics related to variant interpretation and disease-causing mutation identification.

They aim to significantly reduce the average diagnostic time for rare diseases, empowering patients with the right information at the right time to make informed health decisions. Their vision is to make genetic medicine an essential part of healthcare by overcoming the challenges in genomic data interpretation with innovative AI technology.

AION, their flagship AI-powered variant interpretation platform, provides automated, fast, and accurate identification of likely pathogenic variants in less than 2 minutes. It offers a white-box approach to ensure transparency and human expert verifiability, improves diagnostic yield by more than 50%, and is based on a comprehensive and regularly updated database of annotations.

The company boasts a diverse, interdisciplinary team of experts across software, data science, genetics, and healthcare. They value creativity, transparency, kindness, personal responsibility, and continual learning to make a positive societal impact.

Nostos Genomics is GDPR compliant and its AION platform is CE-IVDR certified, demonstrating commitment to data protection and regulatory standards.